Aurobindo has obtained the Food and Drug Administration’s green light for rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. Rivaroxaban tablets are used to reduce the risk of ...
The EINSTEIN-PE Investigators. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism. New England Journal of Medicine. (April 5, 2012) 366;14. The traditional treatment for patients ...
FRANKFURT, May 28 (Reuters) - Bayer AG said it has submitted anti-clotting drug Xarelto for marketing authorisation in Japan for the treatment of deep vein thrombosis and pulmonary embolism, the ...
NEW YORK (AP) — Johnson & Johnson’s Xarelto received an expanded indication as the Food and Drug Administration on Friday approved the blood thinner both to treat and to reduce the risk of recurrence ...
The phase 3 UNIVERSE study evaluated rivaroxaban oral suspension in patients aged 2 to 8 years with single ventricle physiology who had the Fontan procedure. New data were announced from a phase 3 ...
For hospitalized COVID-19 patients with a high risk of venous thromboembolism (VTE) and/or elevated D-dimer levels, along with a low risk of bleeding, use of rivaroxaban 10 mg/day for 35 days after ...
Xarelto is a brand-name prescription medication approved to treat or help prevent harmful blood clots in certain adults and children. A program called the Xarelto withMe Savings Card may be available ...
In the emergency department (ED), it has become common practice to treat deep venous thrombosis (DVT) “below the knee” with enoxaparin (Lovenox) injection prior to discharge, followed by warfarin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results